Data / Drug companies / Ivabradine
Ivabradine: 12 companies and 24 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Ivabradine is listed in the FDA National Drug Code Directory by 12 companies, with 24 products in commercial distribution. 21 of the products (87.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet; solution, and the newest product started marketing on July 1, 2025.
The request: Get every company that lists ivabradine in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 12
- Products
- 24
- Generic (ANDA) products
- 21 (87.5%)
- Application numbers
- 8
- Routes
- Oral
- Brand names
- Corlanor
- openFDA record search
- api.fda.gov
Companies that list ivabradine
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Amgen, Inc | 3 | tablet, film coated; solution | New drug applications (NDA) | April 19, 2019 |
| Alembic Pharmaceuticals Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | December 20, 2024 |
| Alembic Pharmaceuticals Limited | 2 | tablet, film coated | Generic drugs (ANDA) | December 20, 2024 |
| Bionpharma Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | March 1, 2025 |
| Camber Pharmaceuticals, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | October 5, 2022 |
| Golden State Medical Supply, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | December 30, 2021 |
| Ingenus Pharmaceuticals, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | July 15, 2024 |
| NorthStar RxLLC | 2 | tablet, film coated | Generic drugs (ANDA) | April 28, 2025 |
| Novadoz Pharmaceuticals LLC | 2 | tablet, film coated | Generic drugs (ANDA) | April 28, 2025 |
| Zydus Lifesciences Limited | 2 | tablet | Generic drugs (ANDA) | July 2, 2024 |
| Zydus Pharmaceuticals USA Inc. | 2 | tablet | Generic drugs (ANDA) | July 2, 2024 |
| American Health Packaging | 1 | tablet, film coated | Generic drugs (ANDA) | July 1, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 19 | 79.2% |
| Tablet | 4 | 16.7% |
| Solution | 1 | 4.2% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 21 | 87.5% |
| New drug applications (NDA) | 3 | 12.5% |
Pharmacologic classes
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.